Home > Cardiology > ACC/WCC 2020 > Interventional Cardiology > TAVR versus surgery in older patients

TAVR versus surgery in older patients

Presented By
Dr W. Toff, University of Leicester, UK
Conference
ACC 2020
Trial
UK TAVI
In a new, real-world study evaluating patients aged 70 years or older, transcatheter aortic valve replacement (TAVR) was not inferior to surgery with respect to death from any cause at 1 year. Dr William Toff (University of Leicester, UK) presented 1-year follow-up data from UK TAVI study, which involved participants treated at 34 UK sites who were ≥70 years (with additional risk factors) or ≥80 years (with or without additional risk factors) [1]. The mean age was 81 years. The unmet need this trial attempted to address was that although previous clinical trials have found TAVR to be non-inferior or superior to open-heart surgery, most trials have been limited to a younger cohort and mostly only evaluated outcomes from high-volume TAVR centres. The UK TAVI trial enrolled 913 patients who had been referred for treatment of severe aortic stenosis between 2014...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on